A microbiological and clinical review on Corynebacterium kroppenstedtii  by Tauch, Andreas et al.
International Journal of Infectious Diseases 48 (2016) 33–39Review
A microbiological and clinical review on Corynebacterium
kroppenstedtii
Andreas Tauch a, Isabel Ferna´ndez-Natal b,c,*, Francisco Soriano d
aCentrum fu¨r Biotechnologie (CeBiTec), Universita¨t Bielefeld, Bielefeld, Germany
bDepartment of Clinical Microbiology, Complejo Asistencial Universitario de Leo´n, calle Altos de Nava, s/n, 24080 Leo´n, Spain
c Institute of Biomedicine (IBIOMED), Leo´n, Spain
d Public Health, School of Physiotherapy ONCE, Madrid, Spain
A R T I C L E I N F O
Article history:
Received 25 February 2016
Received in revised form 27 April 2016
Accepted 28 April 2016
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark.
Keywords:
Corynebacterium kroppenstedtii
Taxonomy
Breast pathology
Breast abscess
Granulomatous mastitis
Antimicrobial susceptibility
Antibiotic resistance genes
S U M M A R Y
The genus Corynebacterium represents a taxon of Gram-positive bacteria with a high G + C content in the
genomic DNA. Corynebacterium kroppenstedtii is an unusual member of this taxon as it lacks the
characteristic mycolic acids in the cell envelope. Genome sequence analysis of the C. kroppenstedtii type
strain has revealed a lipophilic (lipid-requiring) lifestyle and a remarkable repertoire of carbohydrate
uptake and utilization systems. Clinical isolates of C. kroppenstedtii have been obtained almost
exclusively from female patients and mainly from breast abscesses and cases of granulomatous mastitis.
However, the role of C. kroppenstedtii in breast pathologies remains unclear. This review provides a
comprehensive overview of the taxonomy, microbiology, and microbiological identiﬁcation of C.
kroppenstedtii, including polyphasic phenotypic approaches, matrix-assisted laser desorption/ionization
time-of-ﬂight mass spectrometry, and the use of 16S rRNA gene sequencing. A clinical review presents
reported cases, various antimicrobial treatments, antibiotic susceptibility assays, and antibiotic
resistance genes detected during genome sequencing. C. kroppenstedtii must be considered a potential
opportunistic human pathogen and should be identiﬁed accurately in clinical laboratories.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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The genus Corynebacterium currently comprises almost 100 spe-
cies and represents a very diverse collection of taxonomically
related Gram-positive bacteria (http://www.bacterio.net).1 Some
Corynebacterium species are serious pathogens of humans or
animals, whereas others are useful in industrial applications and in
food production.2 The detection of corynebacteria in various
habitats of the human body has broadened in recent years as a
result of culture-independent approaches and the application of
next-generation DNA sequencing technologies.3,4 These studies
have provided vast sets of 16S rRNA gene sequences, and through
this, a compilation of the bacterial repertoire that is associated
with human beings as commensals or pathogens.5 Developments
in technology have recently led to the generation of three-
dimensional maps of the chemical makeup of the human skin
surface, with correlation to the bacteria of the skin microbiome .6* Corresponding author. Tel.: +34987234900; fax: +34987235165.
E-mail address: ifernandeznatal@gmail.com (I. Ferna´ndez-Natal).
http://dx.doi.org/10.1016/j.ijid.2016.04.023
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Corynebacterium species of the human microbiome have often
been assigned as opportunistic pathogens, as they have rarely been
associated with human infections and have been regarded as
contaminants in clinical specimens.3 Nevertheless, several coryne-
bacteria have been implicated in human disease. The closely
related species Corynebacterium diphtheriae and Corynebacterium
ulcerans, for instance, may produce potent exotoxins, which play
signiﬁcant roles in pathogenicity,7 and Corynebacterium urealyti-
cum has been implicated in urinary tract infections and stone
formation.8
Corynebacterium kroppenstedtii is a true member of the genus
Corynebacterium, but it lacks the typical mycolic acids of the cell
envelope. It was ﬁrst isolated in 1998 from a human sputum
sample,9 and has since occasionally been associated with human
infections, mainly breast abscesses and granulomatous mastitis.
Information on the pathogenicity and antimicrobial susceptibility
of C. kroppenstedtii is relatively scant. This review provides an
overview of the taxonomy and microbiology of C. kroppenstedtii
and summarizes reported cases of C. kroppenstedtii isolation from
clinical specimens. Most C. kroppenstedtii isolates have been
obtained from breast samples. By reviewing all published cases, aciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
A. Tauch et al. / International Journal of Infectious Diseases 48 (2016) 33–3934possible association with breast abscesses and granulomatous
mastitis was sought–an association that needs stronger medical
evidence.
2. Species description
2.1. Taxonomy of C. kroppenstedtii
C. kroppenstedtii has been classiﬁed by chemotaxonomic data
as a member of the genus Corynebacterium.1 According to recent
taxonomic changes, this genus is part of the family Corynebacter-
iaceae, order Corynebacteriales, class Actinobacteria, phylum
Actinobacteria.10–12 This phylum is composed mainly of Gram-
positive bacteria with a high G + C content in the genomic DNA and
exhibits enormous diversity in terms of morphology, physiology,
and metabolic capabilities. The order Corynebacteriales represents
one of the largest groups within the actinobacteria in terms of the
number of species that have been validly published. The species of
this order are characterized by cell wall chemotype IV, which is
deﬁned by the presence of meso-diaminopimelic acid, arabinose,
and galactose in the cell wall, and by the presence of mycolic acids
that are an important component of the cell envelope. Most
Corynebacterium species contain mycolic acids with 22 - 36 car-
bons, although ranges of 20  38 carbons have also been detected.2
Species lacking mycolic acids are Corynebacterium amycolatum,
Corynebacterium caspium, Corynebacterium ciconiae, Corynebacteri-
um lactis, and C. kroppenstedtii.9,13,14 According to genome
sequence data, the lack of mycolic acids in C. kroppenstedtii may
be caused by gene loss, comprising at least a condensase gene
region and a mycolate reductase gene, both contributing to the
biosynthesis of mycolic acids in other corynebacteria.15
The phylogenetic relationship of C. kroppenstedtii with other
Corynebacterium species can be deduced from dendrograms that
generally derive from the alignment of the 16S rRNA or rpoB gene
sequences.2,16,17 The rpoB gene sequence of corynebacteria allows
accurate species identiﬁcation, as it is signiﬁcantly more polymor-
phic than the 16S rRNA gene. Phylogenetic analysis on the basis of
rpoB gene sequence alignment has revealed four clusters in the
genus Corynebacterium with a reliable taxonomic organization
supported by high bootstrap values.16 C. kroppenstedtii has been
assigned as a deeply branching node to cluster 3 of the genus
Corynebacterium, along with Corynebacterium jeikeium, C. urealy-
ticum, and others. In phylogenetic trees based on alignment of
partial 16S rRNA gene sequences, C. kroppenstedtii forms a distinct
clade with the same taxonomic relatives.2,17 This taxonomic
grouping is, moreover, supported by molecular markers of
conserved signature indels (CSIs) of deﬁned lengths that are
present in gene or protein sequences at speciﬁc positions and that
are uniquely shared by particular groups of organisms. One
example of a corynebacterial conserved signature indel is an insert
of seven to eight amino acids in a conserved region of the b0
subunit of RNA polymerase (RpoC) that is generally present in
subclade I of Corynebacterium species, but that is not found in C.
jeikeium, C. urealyticum, C. kroppenstedtii, and other corynebacteria
that are not part of this subclade.18 In addition it has to be noted
that other CSIs speciﬁc for subclade I species or for C. jeikeium and
C. urealyticum are not present in C. kroppenstedtii. The absence of
CSIs for the other two corynebacterial clades in C. kroppenstedtii
suggests that this species forms a distinct evolutionary subgroup in
the genus Corynebacterium.18
2.2. Microbiology of C. kroppenstedtii
C. kroppenstedtii was ﬁrst described in 1998 by Collins et al. who
isolated this bacterium from the sputum of an 82-year-old female
with pulmonary disease.9 The type strain of this species isrepresented by the clinical isolate CCUG 35717 (CIP 105744,
DSM 44385, JCM11950). The cells are Gram-positive, non-motile,
non-spore-forming, non-pigmented, rod-shaped diphtheroids
with typical coryneform morphology. Colonies on blood agar are
non-pigmented to greyish, matt, smooth, round, convex, less than
1 mm in diameter after 24 h of incubation, and non-haemolytic
(Fig. 1).
The organism is catalase-positive and facultatively anaerobic.
The biochemical characteristics of the C. kroppenstedtii type strain
are as follows:9 acid is produced from glucose, maltose, and
sucrose, but not from lactose, mannitol, glycogen, ribose, or D-
xylose. Hydrolysis of aesculin is positive. Some clinical isolates can
produce propionic acid as a metabolic product.19 Positive
biochemical reactions are detected for leucine arylamidase,
esterase C4, ester lipase C8, and pyrazinamidase; negative
reactions for alkaline and acid phosphatases, N-acetyl-b-glucosa-
minidase, cystine arylamidase, chymotrypsin, a-fucosidase, a-
galactosidase, b-galactosidase, a-glucosidase, b-glucosidase, b-
glucuronidase, lipase C14, a-mannosidase, pyrrolidonyl arylami-
dase, trypsin, and valine arylamidase. Nitrate is not reduced to
nitrite; urea is not hydrolyzed. The major long-chain cellular fatty
acids are C16:0, C18:0, and C18:1v9. Tuberculostearic acid is present.
The DNA base composition of the type strain CCUG 35717 is
62 mol% G + C.9
Although C. kroppenstedtii was not considered a lipophilic
Corynebacterium in the initial species description,9 this metabolic
feature was observed in a later study as colonies grew poorly on
sheep blood agar but well on the same medium supplemented
with 1% Tween 80,20 as well as in brain-heart infusion broth with
Tween 80 (Fig. 2). Lipophilism as a metabolic feature of C.
kroppenstedtii has also been deduced from the annotation of the
genome sequence of the type strain.15 The genome sequencing
project suggested that the lipophilic lifestyle of C. kroppenstedtii is
caused by gene loss, comprising the fatty acid synthase gene. This
evolutionary event of gene loss is also detectable in the close
taxonomic relatives of corynebacterial cluster 3, C. jeikeium, C.
urealyticum, Corynebacterium bovis, and Corynebacterium resistens.2
2.3. Microbiological identiﬁcation of C. kroppenstedtii
Accurate microbiological identiﬁcation of C. kroppenstedtii
isolates can be achieved in the clinical laboratory by a combination
of standard biochemical methods. C. kroppenstedtii can be
distinguished from other corynebacteria lacking the characteristic
mycolic acids by several biochemical characteristics (Table 1). API
Coryne (bioMe´rieux, Marcy l’Etoile, France) in its different versions
has been used by many authors.9,19–25 In principle, API Coryne is a
useful tool to complement homemade biochemical tests, but it is
not suitable to identify C. kroppenstedtii as this species is not
included in the respective database. In a few reports in which API
Coryne proﬁling was performed, initially doubtful identiﬁcations
as Propionibacterium acnes21 or Corynebacterium argentoratense22
have been suggested. Bernard et al. described API proﬁles of
2040104 (sucrose-negative) and 2040105 (sucrose-positive) for
two isolates that were both aesculin-positive by API Coryne system
but negative in other media.19 The present authors isolated two
strains associated with granulomatous mastitis with API proﬁles of
2100104 (maltose, sucrose, and aesculin-negative) after 24 h and
2140104 (maltose and sucrose-negative, aesculin-positive) after
48 h.
The results of biochemical tests should be reported stating the
media used and time of incubation, as acid production from
carbohydrates and aesculin hydrolysis might be delayed in many
organisms. This is particularly important in lipophilic corynebac-
teria for which an inoculum of 6 McFarland standard turbidity
must be carefully prepared.26 Moreover, matrix-assisted laser
Fig. 1. Corynebacterium kroppenstedtii: (a) Gram stain; (b) subculture on sheep blood agar after 24 h of incubation in aerobic conditions; (c) subculture on sheep blood agar
after 72 h of incubation in aerobic conditions; (d) subculture on sheep blood agar after 24 h of incubation in aerobic conditions–one drop of Tween 80 was added to the lower
third part of the Petri dish.
Fig. 2. Corynebacterium kroppenstedtii: subculture in brain-heart infusion broth (left
tube) and brain-heart infusion broth enriched with 1% Tween 80 (right tube) after
24 h.
A. Tauch et al. / International Journal of Infectious Diseases 48 (2016) 33–39 35desorption/ionization time-of-ﬂight mass spectrometry (MALDI-
TOF MS), mainly based on Bruker systems, has been established for
the identiﬁcation of clinical Corynebacterium species and has since
successfully complemented classical biochemical approaches.27–31
Using MALDI-TOF MS as described previously, the two coryneform
isolates investigated by the present authors gave signiﬁcant scores
for C. kroppenstedtii of 1.990 and 1.780, values considered accurate
enough for species identiﬁcation.27,31
Determination of the 16S rRNA gene sequences and of the
hypervariable region of the rpoB gene are the reference methods
for taxonomic identiﬁcation of corynebacteria.16,17 16S rRNA gene
sequencing has been used for the accurate identiﬁcation of C.
kroppenstedtii isolates in most published reports,21–25,27,32,33
although DNA–DNA hybridization has also been used.20 Moreover,
a direct PCR technique on clinical samples has been applied
successfully for species identiﬁcation,33,34 which uses broad-range
16S rRNA gene PCR primers and subsequent DNA sequencing.33
3. Clinical review
Data on 42 cases of C. kroppenstedtii isolations from human
clinical samples are presented in Table 2.9,19–25,27,29,30,33–36 The
ﬁrst clinical isolate, which was used for the species description,
was obtained from the sputum of an 82-year-old female patient.9
Table 1
Biochemical characteristics to distinguish Corynebacterium kroppenstedtii from other corynebacteria lacking mycolic acids
Feature C. kroppenstedtiia C. amycolatum C. caspium C. ciconiae C. lactis
Lipophilism +    
Acid is
produced
from:
Glucose + + + + +
Maltose + (weak) + (variable)  + 
Ribose  + + + +
Sucrose + + (variable)   ND
Alkaline
phosphatase
 +  + +
Reduction
of nitrate
 + (variable)   ND
Hydrolysis
of urea
 + (variable) +  
Hydrolysis
of aesculin
+ (variable)    ND
Tuberculostearic
acid
+   ND 
+, feature present;  feature absent; ND, not determined.
a Due to lipophilism and slow growth, it is recommended that the proﬁle is checked after 24 h and 48 h of growth.8
Table 2
Summary of data for 42 cases of Corynebacterium kroppenstedtii isolations from human clinical samples
Reference Age, years Race/ethnicity Diagnosis Specimen obtained PMN seen
in specimen
Bacteria seen
in specimen
Comments
9 82 NR Pulmonary disease Sputum NR NR First description
of the species
19 NR NR Breast abscess Pus NR NR
NR NR NR Lung biopsy NR NR
NR NR NR Sputum NR NR
NR NR NR Blood culture NR NR
24 39 Maori BA Pus 3 + Occasional GPB Recurrent
33 Maori GM Biopsy NR NR
28 Samoan GM Pus 2 + Moderate GPB Recurrent
29 Tongan BA Pus 3 + No
30 Samoan BA Pus 2 + No
22 Unknown BA Pus 2 + No
41 Maori SLG Biopsy 1 + No Mixed with CoNS
31 Samoan GM Pus 3 + Occasional GPB
28 Maori BA Pus 3 + No
34 Filipino BA Pus 3 + No
26 Maori SLG Pus 1 + No
24 Tongan BA Pus 1 + No
36 Fijian GM, SLG Biopsy 3 + Occasional GPC
20 38 NR BA Needle aspiration 3 + No Recurrent
35 26 NR GM Biopsy 3 + No Recurrent
36 47 NR GM Biopsy 1 + NR
21 41 Caucasian GM Percutaneous drainage NR No Defective neutrophilsa
23 46 Caucasian BA Needle biopsy 3 + No Recurrent
25 36 NR BA NR 1 + Some GPB Recurrent
34 34 NR GM NR NR NR Diagnosed by PCR
29 31 Indian GM, BA Biopsy 3 + No Recurrent BA and GM
22 20 Japanese GM Needle aspiration 2 + Few GPB Prednisone and
azathioprinea
34 NR GM Surgical drainage 2 + No
27 47 Caucasian GM NR NR No Recurrent
35 Paciﬁc Islander BA NR NR NR Recurrent
21 Maori GM NR NR No Recurrent
47 Caucasian GM, BA NR NR No Recurrent
42 Caucasian BA NR NR NR
57 Caucasian BA NR NR NR
39 Caucasian NR NR NR NR
38 Paciﬁc Islander BA NR NR NR
34 African GM, BA NR NR No
41 Southeast Asian BA NR NR NR
30 36 Chinese BA Pus 3 + No Recurrent
33 59 NR Endocarditis Valve vegetation Yes GPB
This review 38 Caucasian GM Needle aspiration NP NP Recurrent
This review 45 Caucasian GM Needle aspiration NP NP Recurrent
BA, breast abscess; CoNS, coagulase-negative staphylococci; GM, granulomatous mastitis; GPB, Gram-positive bacilli; GPC, Gram-positive cocci; NP, not performed; NR, not
reported; PMN, polymorphonuclear cells; SLG, suppurative lipogranuloma.
a Immunodeﬁcient.
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one33 were obtained from female patients. Thirty-seven isolates
(88.0%) originated from breast clinical samples, two from
sputum, and one each from lung biopsy, blood culture, and a
prosthetic valve, the latter in a male patient. The ﬁnal diagnosis
in breast pathology cases was breast abscesses in 17 cases
(45.9%), granulomatous mastitis in 13 cases (35.1%), suppurative
lipogranuloma in two cases (5.4%), and mixed diagnosis in four
cases (10.8%) (granulomatous mastitis plus breast abscess in
three cases and granulomatous mastitis plus suppurative
lipogranuloma in one case); a single case was without a
diagnosis (2.7%). Breast abscesses occurred in patients in the
age range of 22–57 years (mean 35.9 years) and granulomatous
mastitis in patients of similar ages (20–47 years, mean
34.5 years). Data on parity were available for 18 women, being
between 1 and 4 (mean 2.7) in patients with breast abscesses
and between 0 and 3 (mean 1.6) in those with granulomatous
mastitis.
Information on ethnicity was obtained for 12 cases of breast
abscesses: three were Caucasian, two were Maori, two were
Tongan, and two were Paciﬁc Islander. Ethnicity was known for
eight patients diagnosed with granulomatous mastitis: four were
Caucasian, two were Maori, one was Samoan, and one was
Japanese. Information on the type of specimen obtained was
available for 24 cases, with pus predominating (16 cases), followed
by biopsies (seven cases) and surgical drainage (two cases). For
these specimens, information on the presence of inﬂammatory
cells and Gram stain results was available for only 11 cases of
breast abscesses. All cases showed polymorphonuclear cells, but
Gram-positive bacteria were detected in only two cases (18.2%).
Data for the cases of granulomatous mastitis showed the presence
of polymorphonuclear cells in ﬁve out of the ﬁve cases and the
presence of Gram-positive bacilli in two out of the seven cases
(28.5%).
The role of C. kroppenstedtii in human mastitis and especially in
granulomatous mastitis needs further investigation. There are
reports of granulomatous mastitis where no organisms have been
isolated.24,32 On the other hand, there are also cases probably
associated with other Corynebacterium species, such as C.
tuberculostearicum, C. amycolatum, C. glucuronolyticum, and C.
freneyi.24,27 Some reports do not provide sufﬁcient information on
the sample quality or on the number of microorganisms recovered.
Frequently, bacteria were not visualized by Gram staining of the
clinical samples. The possibility that C. kroppenstedtii was a
secondary colonizer could not be completely ruled out in some of
the published cases. However, as previously argued,24 the
corynebacterial organisms were frequently found in histological
specimens of breast tissues and in granulomatous mastitis,
surrounded by a granulomatous inﬂammatory reaction, and were
observed relatively early in the clinical presentation. Moreover, it
is well accepted that corynebacteria stain poorly in clinical
samples.24 Nevertheless, granulomatous mastitis is a very complex
entity where the presence of C. kroppenstedtii could be just one
piece of a yet unsolved puzzle.
A case of early prosthetic valve endocarditis in a 59-year-old
male patient diagnosed by PCR and 16S rRNA gene sequencing was
recently published;33 this is the ﬁrst case of this severe disease
caused by C. kroppenstedtii to be described. Coryneforms, usually
accompanied by polymorphonuclear cells, were seen on tissue
smear preparations. The outcome was favourable after surgery and
appropriate antimicrobial treatment. There is no clinical informa-
tion available regarding the isolates obtained from a lung biopsy
and a blood culture.19
Most infections associated with C. kroppenstedtii appear to be
community-acquired and only two patients could be considered as
immunodeﬁcient.21,22A case of otitis externa associated with C. kroppenstedtii has
been described in a peach-faced lovebird that was treated
successfully using topical antiseptics.37
4. Treatment
Information regarding the clinical outcomes in breast patholo-
gies is generally scarce and the follow-up has been short in many
cases. Nevertheless, most cases have involved a torpid and long-
standing process, frequently of months and even years, with
common recurrences of both breast abscesses and granulomatous
mastitis. Regarding the treatment of cases associated with the
detection of C. kroppenstedtii, surgery has been necessary in many
cases of both breast abscesses and granulomatous mastitis, using
multiple incision and drainage procedures. Antibiotics, often
administered for long periods of time, have been associated with
favourable outcomes. The most commonly used antimicrobials
have been doxycycline, amoxicillin (with and without clavulanic
acid), ciproﬂoxacin, and cefuroxime. Some reports have suggested
that lipophilic antibiotics such as doxycycline, ciproﬂoxacin, and
pristinamycin could be more effective for treating breast infections
associated with this organism,23,24 as histological sections have
revealed C. kroppenstedtii cells within vacuoles that probably
contained lipids.24 Antibiotics were not always prescribed for the
treatment of granulomatous mastitis and when used there was
insufﬁcient information regarding doses and the duration of
treatment. In some cases steroids were administered and surgical
procedures varied making it very difﬁcult to draw conclusions on
the efﬁcacy of each procedure. The use of steroids seems to be
appropriate in cases of granulomatous mastitis.38 Most impor-
tantly, no mortality has been reported for any of the cases listed in
Table 2.
The case of prosthetic valve endocarditis by C. kroppenstedtii
required extensive debridement to remove the abscess and
infected tissue along with a sutureless valve implantation.33
Empiric antimicrobial treatment with vancomycin, gentamicin,
and rifampicin was initiated; this was changed to penicillin plus
rifampicin when microbiological data were available, with a
favourable outcome.33
The case of external otitis described in a peach-faced lovebird
was treated successfully with a commercially available acetic and
boric acid solution.37
5. Antibiotic susceptibility assays
For antimicrobial susceptibility testing of corynebacteria, the
broth microdilution technique in cation-adjusted Mueller–Hinton
broth with lysed horse blood (2.5–5%) is recommended by the
Clinical and Laboratory Standards Institute (CLSI), which has
established susceptibility breakpoints for penicillin, vancomycin,
gentamicin, and erythromycin.39 The European Committee on
Antimicrobial Susceptibility Testing (EUCAST) also recommends
the same technique, but has implemented a method for disk
diffusion and deﬁnes susceptibility breakpoints for penicillin,
ciproﬂoxacin, moxiﬂoxacin, gentamicin, vancomycin, clindamycin,
tetracycline, linezolid, and rifampicin.40
Only a few clinical isolates of C. kroppenstedtii have been tested
for antimicrobial susceptibility and most data have been obtained
using the disk diffusion method,9,20,21,23,29,32,33 the Etest,23,27,33
and dilution in Mueller–Hinton broth.25 Many studies have
reported that C. kroppenstedtii isolates are susceptible to most
antibiotics tested, except for fosfomycin.20,23,25 Variable results
have been obtained for co-trimoxazole.23,29,33 Nevertheless,
resistance to penicillin,22,30 imipenem,22 erythromycin,22 and
clindamycin22 has been described. Even applying the rigorous
criteria deﬁned by EUCAST and using the Etest method, resistance
Table 3
Features of Corynebacterium kroppenstedtii genomes
C. kroppenstedtii
strain
Source Genome No. of
genes
No. of pseudogenes No. of
proteins
GenBank ID
Status Size bp G + C %
DSM 44202 Human sputum Complete 2 446 804 57.5 2072 77 1939 CP001620
ITA 105 Human breast Draft 2 574 614 56.8 2208 126 2027 JYCR00000000
ITA 205 Human breast Draft 2 514 376 56.8 2122 93 1976 JYDD00000000
bp, base pairs.
A. Tauch et al. / International Journal of Infectious Diseases 48 (2016) 33–3938to penicillin (91%), ciproﬂoxacin (18%), moxiﬂoxacin (18%), and
clindamycin (9%) has been reported.27 The C. kroppenstedtii strain
isolated from an endocarditis case was studied by disk suscepti-
bility tests following the EUCAST methodology. This organism was
regarded as susceptible to penicillin, clindamycin, rifampicin,
moxiﬂoxacin, vancomycin, and linezolid.33 Minimum inhibitory
concentrations (MICs) determined by Etest were also studied,
being 0.023 mg/l for penicillin and 0.5 mg/l for daptomycin.
The present authors recently studied two clinical C. kroppen-
stedtii strains (ITA105 and ITA205) by Etest and found the
following MICs, given in mg/l: penicillin (0.064/0.023), cefotaxime
(0.047/0.023), imipenem (0.016/0.047), vancomycin (0.75/0.38),
linezolid (0.064/0.064), daptomycin (0.094/0.25), tetracycline (1/
32), ciproﬂoxacin (0.094/ > 32), erythromycin (<0.016/ > 256),
clindamycin (0.032/ > 256), quinupristin/dalfopristin (0.38/ > 32),
gentamicin (0.016/0.032), rifampicin (<0.002/ < 0.002), and co-
trimoxazole (0.032/ > 32).
6. Genome sequences and antibiotic resistance
The application of ultra-fast and high-throughput DNA
sequencing approaches, collectively named next-generation DNA
sequencing technologies, has resulted in detailed insights into the
genome architecture and the gene content of Corynebacterium
species in recent years.2 Prominent features of C. kroppenstedtii
genomes are summarized in Table 3. In 2008, the complete genome
sequence of the type strain C. kroppenstedtii DSM 44385 was
published, along with a detailed annotation of the central carbon
metabolism and the deduced lifestyle.15 The genome project
revealed a large repertoire of genes involved in the uptake of
various sugars, and consequently a complex central carbon
metabolism.
In 2015, draft genome sequences of the antibiotic-sensitive
strain C. kroppenstedtii ITA105 (CNM633/14) and the multidrug-
resistant strain C. kroppenstedtii ITA205 (CNM632/14) were
determined, both isolated from cases of granulomatous mastitis.41
The current three genome sequences show that the C. kroppen-
stedtii chromosome has a size range of 2.44 Mbp to 2.57 Mbp and a
chromosomal G + C content ranging from 56.8% to 57.5%. The
number of protein-coding genes predicted by bioinformatic
methods is in the range of 2000 (Table 3).
The antibiotic resistance genes of the multidrug-resistant
isolate CNM633/14 were allocated to a speciﬁc genomic island
with signiﬁcant similarity to the R plasmid pJA144188 of C.
resistens DSM 45100.42 This resistance island includes the
antibiotic resistances genes erm(X), tet(W), aphA1-IAB, strA, strB,
cmx, and sul1 known from other corynebacteria.2 The erm(X) gene
encodes a 23S rRNA methyltransferase and confers cross-resis-
tance in corynebacteria to many macrolides and lincosamides,
including azithromycin, erythromycin, josamycin, midecamycin,
roxithromycin, spiramycin, tylosin, clindamycin, and lincomycin,
and to the streptogramin B antibiotics quinupristin and pristina-
mycin IA. The tet(W) gene confers cross-resistance to tetracycline
and minocycline in corynebacteria by a ribosomal protection
mechanism. Broad aminoglycoside resistance is mediated by theaphA1-IAB gene and the strA–strB gene pair. The former gene,
encoding an aminoglycoside 30-phosphotransferase, can provide
resistance to kanamycin, neomycin, lividomycin, paromomycin,
and ribostamycin in corynebacteria; the latter genes encode the
enzymes aminoglycoside 30 0-phosphotransferase Ib and aminogly-
coside 6-phosphotransferase Id and speciﬁcally confer streptomy-
cin resistance. The cmx gene codes for an efﬂux protein of the major
facilitator superfamily and is involved in chloramphenicol resis-
tance, whereas the sul1 gene encodes a dihydropteroate synthase
that can confer resistance to a broad spectrum of sulfonamides.42
7. Future perspectives
All except ﬁve reported C. kroppenstedtii strains have been
isolated from the breasts of females, mostly from patients with
breast abscesses and granulomatous mastitis. Approximately 50%
of breast abscesses are caused by Staphylococcus aureus, but all
other cases are produced by mixed anaerobes, anaerobic cocci,
coagulase-negative staphylococci, and others.43 Non-lactational
cases are frequently recurrent and difﬁcult to treat, as observed in
cases where Corynebacterium species, including C. kroppenstedtii,
have been involved. For these reasons, surgery and long courses of
antibiotics are usually necessary to attain cure.
Granulomatous mastitis is an inﬂammatory breast disease
thought to be of unknown aetiology that generally affects women
of child-bearing age, usually within a few years after they have given
birth.24 The disease can become chronic and disﬁguring and it can be
confused with a tumour. Mammary granulomas have been
associated with tuberculosis, sarcoidosis, fungal infections, and
Wegener’s granulomatosis, but since 2002 they have also been
associated with infection by C. kroppenstedtii. The role of this
organism as a cause or complicating factor of granulomatous
mastitis has been demonstrated by several authors,21,22,24,27,29,34–36
but further clinical and histopathological studies are necessary to
clarify its real role in this disease. In many cases, long courses of
antibiotics with or without surgery have been necessary for cure. A
search for the best antimicrobial therapy should be carried out,
taking into account the site where the infection occurs as well as host
factors. Furthermore the ecology of this organism should be studied,
as well as its microbiological features, in order to determine the
unknown mechanisms of pathogenicity.
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